药明康德
(603259)
| 流通市值：1287.47亿 | | | 总市值：1486.74亿 |
| 流通股本：25.01亿 | | | 总股本：28.88亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 14,051,541,214.47 | 14,672,093,741.8 | 15,725,570,254.99 | 13,764,058,665.13 |
| 衍生金融资产 | 100,894,684.14 | - | 37,225.17 | 414,035,113.41 |
| 应收票据及应收账款 | 8,113,218,071.54 | 7,638,747,350.42 | 6,980,250,443.77 | 7,921,577,166.99 |
| 其中：应收票据 | 98,674,289.85 | 24,973,275.65 | 11,415,554.42 | 20,196,868.46 |
| 应收账款 | 8,014,543,781.69 | 7,613,774,074.77 | 6,968,834,889.35 | 7,901,380,298.53 |
| 预付款项 | 238,754,273.51 | 238,989,680.12 | 280,593,477.56 | 243,663,367.83 |
| 其他应收款合计 | 305,029,806.15 | 270,971,533.27 | 195,540,264.83 | 168,176,303.89 |
| 其中:应收利息 | 176,776,121.11 | 121,580,443.18 | 66,790,776.08 | 10,174,736.26 |
| 存货 | 5,347,792,758.02 | 5,231,933,570.54 | 5,047,973,507.51 | 4,736,229,956.28 |
| 合同资产 | 1,135,031,691.43 | 1,200,830,900.09 | 1,249,531,079.54 | 1,234,393,855.26 |
| 一年内到期的非流动资产 | - | - | - | 785,779,534.14 |
| 其他流动资产 | 1,170,486,377.86 | 1,007,571,472.87 | 1,170,811,545.8 | 1,143,553,809.85 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 30,462,748,877.12 | 30,261,138,249.11 | 31,153,381,549.19 | 30,422,470,960.82 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,370,173,557.65 | 2,381,923,736.85 | 2,296,311,550.61 | 2,215,629,616.25 |
| 其他非流动金融资产 | 8,660,659,670.2 | 8,939,253,128.08 | 8,742,143,693.9 | 8,626,009,050.68 |
| 固定资产 | 18,342,952,353.55 | 17,621,506,748.07 | 17,575,822,049.45 | 17,189,915,307.85 |
| 在建工程 | 6,026,413,201.93 | 6,668,400,659.93 | 6,713,410,097.21 | 6,982,392,940.58 |
| 生产性生物资产 | 1,096,719,000 | 1,097,914,000 | 1,050,588,000 | 1,012,478,000 |
| 使用权资产 | 1,491,572,314.82 | 1,410,784,503.01 | 1,352,274,873.41 | 1,391,213,425.45 |
| 无形资产 | 1,793,353,509.96 | 1,823,982,575.64 | 1,844,807,086.6 | 1,863,800,704.15 |
| 商誉 | 1,836,575,496.99 | 1,841,157,784.16 | 1,834,739,575.86 | 1,820,872,684.75 |
| 长期待摊费用 | 1,646,432,316.09 | 1,753,782,178.94 | 1,766,173,788.59 | 1,679,721,310.08 |
| 递延所得税资产 | 402,915,003.64 | 489,518,225.96 | 505,974,800.79 | 366,691,216.7 |
| 其他非流动资产 | 107,724,573.28 | 107,966,867.14 | 104,220,670.96 | 98,154,089.81 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 43,775,490,998.11 | 44,136,190,407.78 | 43,786,466,187.38 | 43,246,878,346.3 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 74,238,239,875.23 | 74,397,328,656.89 | 74,939,847,736.57 | 73,669,349,307.12 |
| 流动负债: | | | | |
| 短期借款 | 2,704,989,653.78 | 2,890,080,979.01 | 2,911,607,355.81 | 3,667,059,680.42 |
| 衍生金融负债 | 64,242,595.44 | 659,740,687.06 | 793,455,403.97 | 501,871,397.56 |
| 应付票据及应付账款 | 1,998,329,644.58 | 1,980,814,621.54 | 1,698,718,898.46 | 1,645,321,546.91 |
| 应付账款 | 1,998,329,644.58 | 1,980,814,621.54 | 1,698,718,898.46 | 1,645,321,546.91 |
| 合同负债 | 2,471,385,961.82 | 2,522,712,030.04 | 2,162,512,791.23 | 1,955,363,182.24 |
| 应付职工薪酬 | 1,611,274,803.01 | 1,285,670,416.82 | 1,228,857,120.15 | 2,125,635,919.87 |
| 应交税费 | 950,547,330.94 | 720,300,487.38 | 1,250,979,804.45 | 1,373,741,119.25 |
| 其他应付款合计 | 2,855,245,818.77 | 3,325,165,815.1 | 3,081,008,697.73 | 3,192,265,947.14 |
| 其中:应付利息 | 27,969,705.3 | 30,133,072.45 | 58,610,968.47 | 22,292,809.61 |
| 应付股利 | - | 355,762,760.94 | - | - |
| 一年内到期的非流动负债 | 271,405,290.68 | 263,890,411.36 | 260,292,810.74 | 295,037,372.18 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 12,927,421,099.02 | 13,648,375,448.31 | 13,387,432,882.54 | 14,756,296,165.57 |
| 非流动负债: | | | | |
| 长期借款 | 2,911,138,289.87 | 2,892,344,085.84 | 2,863,036,640.84 | 687,016,640.84 |
| 租赁负债 | 1,202,535,032.59 | 1,119,844,863.77 | 1,059,414,841.75 | 1,098,552,195.37 |
| 递延收益 | 1,019,988,401.76 | 1,045,104,011.53 | 1,064,935,357.45 | 1,079,932,389.7 |
| 递延所得税负债 | 593,914,950 | 596,899,068.16 | 516,731,002.43 | 530,106,502.9 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 5,727,576,674.22 | 5,654,192,029.3 | 5,504,117,842.47 | 3,395,607,728.81 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 18,654,997,773.24 | 19,302,567,477.61 | 18,891,550,725.01 | 18,151,903,894.38 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,911,927,203 | 2,911,927,203 | 2,933,327,890 | 2,968,844,903 |
| 资本公积 | 25,575,508,845.13 | 25,482,743,813.51 | 26,366,560,790.01 | 28,401,011,161.7 |
| 减:库存股 | 3,870,742,317.26 | 1,964,735,534.49 | 2,301,372,915.99 | 3,156,528,928.12 |
| 其他综合收益 | 109,148,911.82 | 129,409,077.93 | -98,059,863.64 | 112,305,624.84 |
| 盈余公积 | 1,023,342,127.82 | 1,023,342,127.82 | 1,023,342,127.82 | 1,023,342,127.82 |
| 未分配利润 | 29,424,362,889.87 | 27,131,250,204.7 | 27,715,689,715.14 | 25,773,479,021.49 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 55,173,547,660.38 | 54,713,936,892.47 | 55,639,487,743.34 | 55,122,453,910.73 |
| 少数股东权益 | 409,694,441.61 | 380,824,286.81 | 408,809,268.22 | 394,991,502.01 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 55,583,242,101.99 | 55,094,761,179.28 | 56,048,297,011.56 | 55,517,445,412.74 |
| 负债和股东权益合计 | 74,238,239,875.23 | 74,397,328,656.89 | 74,939,847,736.57 | 73,669,349,307.12 |
| 公告日期 | 2024-10-29 | 2024-07-30 | 2024-04-30 | 2024-03-19 |
| 审计意见(境内) | | | | 标准无保留意见 |